Solara Active Pharma Sciences (NSE:SOLARA) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SOLARA Solara Active Pharma Sciences Ltd NSE:SOLARA
68 GF Score
Price ₹570.80
GF Value ₹570.64
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Solara Active Pharma Sciences Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:SOLARA vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solara Active Pharma Sciences Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Short Interest distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's Short Interest falls into.


NSE:SOLARA
68GF Score
Solara Active Pharma Sciences Ltd NSE:SOLARA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Solara Active Pharma Sciences (NSE:SOLARA) Overvalued in 2026?

Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued. The current stock price of ₹570.80 is trading 0% above its estimated GF Value™ of ₹570.64. GuruFocus considers Solara Active Pharma Sciences to be Fairly Valued.

Key valuation signals for NSE:SOLARA:

  • Short Interest:
  • GF Value™: ₹570.64 vs. price of ₹570.80 (0% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the NSE:SOLARA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solara Active Pharma Sciences Business Description

Other Exchanges 541540:India
Address Phase II - CSIR Road, Module No. 601, 602, 603, Ticel Bio Park, Taramani, Chennai, TN, IND, 600113
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
68GF Score

Get the complete analysis for NSE:SOLARA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹570.80
Price
₹570.64
GF Value